H
HUMAW
Humacyte Inc
0.1200
+0.0262+27.93%Opening13:09 04/07 EDT
OPEN/PREV CLOSE0.0942/0.0938
TODAY RANGE0.0916-0.1200
VOL18.01K
MARKET CAP--
52 WEEK RANGE0.0822-0.6500
AVG VOL (3M)16.37K
% TURNOVER0%
TURNOVER0
P/E (TTM)-0.4648
% RANGE30.28%
EPS(TTM)-0.2582
P/E(FORWARD)--
P/B7.45
BVPS0.0161
DIVIDEND--
P/S11.32
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP--
SHARES OUTSTANDING--
NEXT EARNINGS--
FREE FLOAT--
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·2h ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·19h ago
Largest borrow rate increases among liquid names
Benzinga·03/31 16:00
This Rockwell Automation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Dow Jones·03/31 15:25
Humacyte Price Target Cut to $1.00/Share From $10.00 by Benchmark
Dow Jones·03/31 15:25
Humacyte Cut to Speculative Buy From Buy by Benchmark
Benzinga·03/31 15:18
Benchmark Downgrades Humacyte to Speculative Buy, Lowers Price Target to $1
TipRanks·03/31 13:30
Humacyte downgraded to Speculative Buy from Buy at Benchmark
TipRanks·03/31 12:50
Largest borrow rate increases among liquid names
Reuters·03/31 07:39
U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks
Dow Jones·03/30 18:04
Humacyte Is Maintained at Neutral by Piper Sandler
Dow Jones·03/30 18:04
Humacyte Price Target Cut to $1.00/Share From $3.00 by Piper Sandler
Benzinga·03/30 17:53
Piper Sandler Maintains Neutral on Humacyte, Lowers Price Target to $1
Dow Jones·03/30 13:26
Humacyte Is Maintained at Buy by TD Cowen
Same Industry
Name/Symbol
Change%
Price